Brought to you by 
Boston Scientific acquires EndoTex Interventional Systems
Jan 2007
Executive Summary
Upping its 20% shareholding, Boston Scientific has now acquired EndoTex Interventional Systems, a company that is developing devices to treat carotid artery disease. BS issued 5mm shares worth $90mm to EndoTex stockholders, as well as $10mm in cash.
Deal Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Stock
- Includes Earnout
- Partial Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific acquires EndoTex Interventional Systems
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice